Abstract
Retrospective analysis of newly diagnosed gout cases seen at the Mayo Clinic from 1949 through 1972 shows a progressive decline in tophaceous gout, from 14% to 3%. Gout diagnoses remained stable in a range of 1.5 to 2.2/1,000 patients seen.
MeSH terms
-
Colchicine / therapeutic use
-
Gout / drug therapy
-
Gout / epidemiology*
-
Gout / prevention & control
-
Humans
-
Minnesota
-
Probenecid / therapeutic use
-
Retrospective Studies
-
Sulfinpyrazone / therapeutic use
Substances
-
Probenecid
-
Colchicine
-
Sulfinpyrazone